Larry Smith Profile
Larry Smith

@SmithOnStocks1

Followers
278
Following
8
Media
0
Statuses
43

Joined October 2020
Don't wanna be here? Send us removal request.
@SmithOnStocks1
Larry Smith
2 years
$nwbo I have taken the transcript from Linda Power’s comments at the annual meeting and edited and organized them to make for easier reading. It contains a wealth of valuable information. I have also included my key takeaways. The report is free .
smithonstocks.com
Glossary of Key Acronyms Used in this Report MHRA Medicines and Healthcare products Regulatory Agency is the United Kingdom regulatory counterpart to FDA. The two agencies have a close, collegial...
10
32
134
@SmithOnStocks1
Larry Smith
2 years
The decision on Citadel, et al's motion to dismiss is likely to be released in four to six weeks. This leads me to republish a report on this issue earlier this year.
smithonstocks.com
Key Points: I believe that the lawsuit will be allowed to go to discovery before or around mid-year. This will allow access to the trading records and computer algorithms used by market makers to...
0
9
41
@SmithOnStocks1
Larry Smith
2 years
$NWBO I have just published a new report on the lawsuit. It can be accessed at this link. https://t.co/MU6eqJKgTd Ignore the message that you need to subscribe to access the report. It is free.
smithonstocks.com
Key Points: I believe that the lawsuit will be allowed to go to discovery before or around mid-year. This will allow access to the trading records and computer algorithms used by market makers to...
3
22
99
@SmithOnStocks1
Larry Smith
2 years
I published a report last week "Highly Probable UK Approval of DCVax-L in 1H, 2024 Would Be a Crowning Achievement" for Northwest Biotherapeutics https://t.co/DFO5oBKC3L Firewall issues prevented some from seeing it, but this has been corrected. The report is free.
smithonstocks.com
Key Points: On December 21, 2023, NWBO announced that it had submitted its MAA seeking regulatory approval for DCVax-L in the UK. The Company requested that MHRA review DCVax-L using the accelerated...
9
27
102
@SmithOnStocks1
Larry Smith
2 years
$nwbo I have summarized my latest thoughts on NWBO in a report “Highly Probable UK Approval of DCVax-L in 1H, 2024 Would Be a Crowning Achievement for Northwest Biotherapeutics”. This can be accessed free of charge at this link.
smithonstocks.com
Key Points: On December 21, 2023, NWBO announced that it had submitted its MAA seeking regulatory approval for DCVax-L in the UK. The Company requested that MHRA review DCVax-L using the accelerated...
7
30
125
@SmithOnStocks1
Larry Smith
2 years
I wrote this report on the importance of the approval for the commercial manufacturing of DCVax-L at Sawston last April. Thought I would republish.
smithonstocks.com
Acronyms Used in This Report MHRA Medicines and Healthcare products Regulatory Agency is the United Kingdom regulatory counterpart to FDA. The two agencies have a close, collegial working relations...
4
18
79
@SmithOnStocks1
Larry Smith
3 years
$nwbo Why I believe that NWBO has been the subject of a collusion between market makers and hedge funds to artificially drive the price to levels orders of magnitude below it would be without the manipulation.
smithonstocks.com
DCVax-L Impressive Phase 3 Results Are Validated by Independent, Expert Scientists and Physicians; Supports Strong Upward Stock Move The final results of the phase 3 trial of DCVax-L were first...
8
34
115
@SmithOnStocks1
Larry Smith
3 years
$nwbo The commercial licensing of Sawston likely confers to it a value of several hundred million dollars. This is a new and very important part of the NWBO inv thesis apart from DCVax-L. See my report.
smithonstocks.com
Acronyms Used in This Report MHRA Medicines and Healthcare products Regulatory Agency is the United Kingdom regulatory counterpart to FDA. The two agencies have a close, collegial working relations...
12
40
122
@SmithOnStocks1
Larry Smith
3 years
$nwbo Feuerstein continues to gaslight the DCVax-L phase 3 trial falsely claiming that the endpoint was PFS. Here are the actual facts.
smithonstocks.com
Executive Summary I have tried to make this report as short and readable as possible so that in many cases I provide links to a previous article I have written or other pertinent data, rather than...
7
40
111
@SmithOnStocks1
Larry Smith
3 years
$NWBO Creating counterfeit shares through illegal naked shorting is at the heart of Wall Street's rampant manipulation of securities, which by some estimates accounts for as much as 20% of Street profits. In part, this is how it is done with stocks.
smithonstocks.com
Acronyms Used Frequently in This Report DTCC: The Depository Trust & Clearing Corporation (DTCC) provides clearing and settlement services to the US financial markets that handle the exchange of...
0
13
46
@SmithOnStocks1
Larry Smith
3 years
$NWBO Feuerstein says there is no spoofing or market manipulation. His old firm https://t.co/1cnJB3mZ6X disagrees. https://t.co/yza0qBFq2I Also Citadel just paid a $10 million fine in Japan for spoofing.
6
25
97
@SmithOnStocks1
Larry Smith
3 years
$NWBO $GNS Creating counterfeit shares through illegal naked shorting is at the heart of Wall Street's rampant manipulation of securities, which by some estimates accounts for as much as 20% of Street profits. In part, this is how it is done with stocks.
smithonstocks.com
Acronyms Used Frequently in This Report DTCC: The Depository Trust & Clearing Corporation (DTCC) provides clearing and settlement services to the US financial markets that handle the exchange of...
1
10
40
@SmithOnStocks1
Larry Smith
3 years
$NWBO Feuerstein says there is no spoofing or market manipulation. His old firm https://t.co/1cnJB3mZ6X disagrees. https://t.co/yza0qBFq2I Also Citadel just paid a $10 million fine in Japan for spoofing.
6
25
97
@SmithOnStocks1
Larry Smith
3 years
$NWBO Investors don't own shares of NWBO. They are owned by CEDE, a subsidiary of DTCC which in turn is owned by Wall Street firms. You own a fungible, digital derivative of registered shares which is key to creation of counterfeit shares. See
smithonstocks.com
You Really Don’t Own the Shares that Appear in Your Brokerage Account; They Belong to Cede Most investors when they buy a publicly traded stock believe that they own a part of some company. They...
4
10
44
@SmithOnStocks1
Larry Smith
3 years
$NWBO Investors don't own shares of NWBO. They are owned by CEDE, a subsidiary of DTCC which in turn is owned by Wall Street firms. You own a fungible, digital derivative of registered shares which is key to creation of counterfeit shares. See
smithonstocks.com
You Really Don’t Own the Shares that Appear in Your Brokerage Account; They Belong to Cede Most investors when they buy a publicly traded stock believe that they own a part of some company. They...
4
10
44